Format
Sort by
Items per page

Send to

Choose Destination

Best matches for CYCLOPHOSPHAMIDE ANHYDROUS/TU:

Effect of Paclitaxel on Antitumor Activity of Cyclophosphamide: Study on Two Transplanted Tumors in Mice. Kaledin VI et al. Bull Exp Biol Med. (2015)

The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy. Ahlmann M et al. Cancer Chemother Pharmacol. (2016)

Cyclophosphamide in severe aplastic anemia? Peffault de Latour R et al. Blood. (2014)

Search results

Items: 1 to 20 of 40720

1.

Adolescent PR3-ANCA-positive hypertrophic pachymeningitis: A case report and review of the literature.

Matsumoto K, Akiyama M, Kajio N, Otomo K, Suzuki K, Nishina N, Kasuya K, Oishi N, Kameyama K, Takeuchi T.

Medicine (Baltimore). 2018 Apr;97(17):e0521. doi: 10.1097/MD.0000000000010521.

2.

A new intensive conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with refractory or relapsed acute myeloid leukemia.

Wang J, Zhao J, Fei X, Yin Y, Cheng H, Zhang W, Gu J, Yang F, Yang Y, Xue S, Tian Z, He J, Zhang S, Wang X.

Medicine (Baltimore). 2018 Apr;97(17):e0228. doi: 10.1097/MD.0000000000010228.

3.

Pregnancy-induced complications in IgA nephropathy: A case report.

Chen H, Li X, Wu Y, Fan L, Tian G.

Medicine (Baltimore). 2018 Apr;97(15):e0470. doi: 10.1097/MD.0000000000010470.

4.

Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report.

Endo Y, Koga T, Suzuki T, Hara K, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kuwana M, Kawakami A.

Medicine (Baltimore). 2018 Apr;97(15):e0436. doi: 10.1097/MD.0000000000010436.

5.

Hydroa vacciniforme-like cutaneous T-cell lymphoma in a child: A case report.

Li J, Zan Y, Liu H, Liu H, Chen L.

Medicine (Baltimore). 2018 Apr;97(15):e0319. doi: 10.1097/MD.0000000000010319.

6.

Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach.

de Jong MRW, Visser L, Huls G, Diepstra A, van Vugt M, Ammatuna E, van Rijn RS, Vellenga E, van den Berg A, Fehrmann RSN, van Meerten T.

PLoS One. 2018 Feb 28;13(2):e0193098. doi: 10.1371/journal.pone.0193098. eCollection 2018.

7.

[Rectal diffuse large B cell lymphoma appearing after immunosuppression for ulcerative colitis. Report of one case].

Quera R, Flores L, Simian D, Kronberg U, Vial MT, de Guevara DL, García-Rodríguez MJ.

Rev Med Chil. 2017 Oct;145(10):1342-1348. doi: 10.4067/S0034-98872017001001342. Spanish.

8.

Immune-enhancing activity of C. militaris fermented with Pediococcus pentosaceus (GRC-ON89A) in CY-induced immunosuppressed model.

Kwon HK, Jo WR, Park HJ.

BMC Complement Altern Med. 2018 Feb 23;18(1):75. doi: 10.1186/s12906-018-2133-9.

9.

Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.

Romano A, Parrinello NL, Vetro C, Chiarenza A, Cerchione C, Ippolito M, Palumbo GA, Di Raimondo F.

Ann Hematol. 2018 Jun;97(6):1009-1018. doi: 10.1007/s00277-018-3276-y. Epub 2018 Feb 14.

PMID:
29442162
10.

Burkitt's lymphoma: The prevalence of HIV/AIDS and the outcome of treatment.

Hesseling PB, Kouya F, Katayi E, Mbah G, Wharin P.

S Afr Med J. 2018 Feb 1;108(2):84-85. doi: 10.7196/SAMJ.2017.v108i2.12441.

11.

Ratio of Immune Response to Tumor Burden Predicts Survival Via Regulating Functions of Lymphocytes and Monocytes in Diffuse Large B-Cell Lymphoma.

Ji H, Niu X, Yin L, Wang Y, Huang L, Xuan Q, Li L, Zhang H, Li J, Yang Y, An W, Zhang Q.

Cell Physiol Biochem. 2018;45(3):951-961. doi: 10.1159/000487288. Epub 2018 Feb 2.

12.

Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma.

Kanemasa Y, Shimoyama T, Sasaki Y, Hishima T, Omuro Y.

Ann Hematol. 2018 Jun;97(6):999-1007. doi: 10.1007/s00277-018-3273-1. Epub 2018 Feb 9.

PMID:
29427185
13.

Synchronous papillary thyroid cancer and non-Hodgkin lymphoma: Case report.

Popivanov GI, Bochev P, Hristoskova R, Mutafchiyski VM, Tabakov M, Philipov A, Cirocchi R.

Medicine (Baltimore). 2018 Feb;97(6):e9831. doi: 10.1097/MD.0000000000009831.

14.

Hypocomplementemic Urticarial Vasculitis Syndrome With Crescentic Glomerulonephritis.

Salim SA, Yousuf T, Patel A, Fülöp T, Agarwal M.

Am J Med Sci. 2018 Feb;355(2):195-200. doi: 10.1016/j.amjms.2017.04.004. Epub 2017 Apr 8.

PMID:
29406049
15.

[The clinical characteristics of Takayasu's arteritis with glomerulonephropathy].

Chen Z, Yang YJ, Li J, Tian XP.

Zhonghua Nei Ke Za Zhi. 2018 Feb 1;57(2):129-133. doi: 10.3760/cma.j.issn.0578-1426.2018.02.009. Chinese.

PMID:
29397599
16.

[A Case Report of Inguinal Malignant Lymphoma after Surgery for Hepatocellular Carcinoma].

Ohzato Y, Murakami M, Shimizu J, Koga C, Marukawa D, Yoshida Y, Yasuyama A, Matsumura T, Takada A, Kameda C, Kawabata R, Hirota M, Noura S, Miwa H, Hasegawa J.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1638-1640. Japanese.

PMID:
29394727
17.

Systematic evaluation of different doses of cyclophosphamide induction therapy for lupus nephritis.

Tian M, Song X, Dong L, Xin X, Dong J.

Medicine (Baltimore). 2017 Dec;96(51):e9408. doi: 10.1097/MD.0000000000009408. Review.

18.

Coexistence of t(2;14;11)(p16.1;q32;q23) and t(14;19)(q32;q13.3) chromosome translocations in a patient with chronic lymphocytic leukemia: A case report.

Liu G, Wen Z, Lu X, Kim YM, Wang X, Crew RM, Cherry MA, Li S, Liu Y.

Medicine (Baltimore). 2017 Dec;96(51):e9169. doi: 10.1097/MD.0000000000009169.

19.

Endostar combined with chemotherapy in a pediatric osteosarcoma with pulmonary metastasis and malignant pleural effusion: A case report.

Jiang S, Wang G, Dong Y.

Medicine (Baltimore). 2017 Dec;96(51):e9077. doi: 10.1097/MD.0000000000009077.

Supplemental Content

Loading ...
Support Center